These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 38702615

  • 21. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y.
    Cardiovasc Diabetol; 2020 Jul 23; 19(1):116. PubMed ID: 32703284
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
    Wang P, Qiao H, Wang R, Hou R, Guo J.
    BMC Cardiovasc Disord; 2020 Dec 04; 20(1):510. PubMed ID: 33276720
    [Abstract] [Full Text] [Related]

  • 26. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
    Zhang L, Wang Y, Zhang Z, Liang H, Wu L, Ni L, Gao G, Yang D, Zhao H, Xiao J.
    BMC Cardiovasc Disord; 2021 Sep 15; 21(1):438. PubMed ID: 34525967
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M, Yan X, Wu W.
    BMC Cardiovasc Disord; 2021 Sep 17; 21(1):446. PubMed ID: 34535088
    [Abstract] [Full Text] [Related]

  • 29. Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes.
    Yang X, Li K, Wen J, Yang C, Li Y, Xu G, Ma Y.
    Cardiovasc Diabetol; 2024 Jan 13; 23(1):24. PubMed ID: 38218893
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A, Tekiner F, Karakurt A, Sirin G, Duman D.
    Coron Artery Dis; 2014 Sep 13; 25(6):469-73. PubMed ID: 24614629
    [Abstract] [Full Text] [Related]

  • 32. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
    Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B.
    Cardiovasc Diabetol; 2023 Mar 30; 22(1):75. PubMed ID: 36997935
    [Abstract] [Full Text] [Related]

  • 33. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA, Minha S, Chen F, Torguson R, Omar AF, Loh JP, Escarcega RO, Lipinski MJ, Baker NC, Kitabata H, Ota H, Suddath WO, Satler LF, Pichard AD, Waksman R.
    Circ Cardiovasc Interv; 2014 Dec 30; 7(6):768-76. PubMed ID: 25466551
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May 30; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.